Authors

Karen L. Reckamp, MD, MS, City of Hope

Karen Masino, CNP, ACNP-BC, AOCNP, RN

Latest:

Karen Masino on Building a Survivorship Program

Karen Masino, from Ingalls Memorial Hospital, discusses the intricacies of developing a survivorship program.

Karen Masino, MS, CNP, ACNP-BC, AOCNP, RN, RD, LDN

Latest:

Screening and Management: Distress and the Nurse Navigator, Part II

Cancer and its treatment creates or aggravates psychosocial distress, while unresolved physical and practical problems can also add to the distress of patients attempting to complete their treatment and recovery.

Karen Pinilla Alba, MD

Latest:

Dr. Pinilla Alba on Safety Findings of the PARTNER Trial in Breast Cancer

Karen Pinilla Alba, MD, discusses the safety findings stages 1 and 2 of the phase II/III PARTNER trial in triple negative and/or germline BRCA-mutated breast cancer.

Karen Reckamp, MD

Latest:

Reckamp Discusses the Integration of Pragmatic Elements Into Oncology Clinical Trial Designs

Dr Reckamp discusses the definition of pragmatic clinical trials and ways that clinical trial investigators can make their research more pragmatic.

Karen Reckamp, MD, MS

Latest:

Dr. Reckamp on the Significance of ALTA in ALK+ NSCLC

Karen L. Reckamp, MD, discusses the significance of the final results of the ALTA trial in patients with ALK-positive non–small cell lung cancer.

Kari Wisinski, MD

Latest:

Dr Wisinski on Treatment Developments in HR+/HER2– Breast Cancer

Kari Wisinski, MD, discusses treatment development and the current arsenal for patients with hormone receptor–positive, HER2-negative breast cancer.

Kari Young, CPA

Latest:

A "Perfect Storm" Drove Independent to Merge With Hospital

As many hard-pressed physician practices have been doing in the present healthcare environment, our oncology practice also had to take a hard look at our operational design, strategy for the future, and sustainability.

Karim A. Touijer, MD

Latest:

Dr. Touijer on Surgical Options for Patients with RCC

Karim A. Touijer, MD, MPH, surgeon, Memorial Sloan Kettering Cancer Center, discusses the considering factors for surgical options for patients with renal cell carcinoma (RCC).

Karim Fizazi, MD, PhD

Latest:

Dr. Fizazi Discusses Updated Data With Darolutamide in CRPC

Karim Fizazi, MD, PhD, head, Department of Cancer Medicine, Gustave Roussy Cancer Center, Villejuif, France, discusses updated data with darolutamide in castration-resistant prostate cancer.

Karl Lewis, MD

Latest:

Dr. Lewis on Sequencing Strategies in Melanoma

Karl Lewis, MD, medical oncologist, associate professor, University of Colorado, discusses sequencing strategies for the treatment of melanoma.

Karl M. Kilgore, PhD

Latest:

Characteristics, Healthcare Utilization, and Costs of Medicare Patients Receiving CAR T-Cell Therapy

Karl M. Kilgore, PhD, senior research scientist, Avalere Health, discusses real-world data regarding Medicare patients with non-Hodgkin lymphoma receiving CAR T-cell therapy.

Karmanos Cancer Institute

Latest:

Karmanos Cancer Institute Implements New Bar Code Validation Software for Clinical Trial Drugs

The new process checking system makes sure the right drugs are dispensed, improving patient safety.

Karon Martyn, MSN, ANP-BC, AOCNP

Kartik Konduri, MD

Latest:

Dr. Konduri on Sequencing Challenges in ALK+ NSCLC

Kartik Konduri, MD, discusses remaining sequencing challenges in ALK-positive non–small cell lung cancer.

Karyn A. Goodman, MD

Latest:

Dr. Goodman on the Use of SBRT in Locally Advanced Pancreatic Cancer

Karyn A. Goodman, MD, MS, discusses key toxicity and efficacy data supporting the use of stereotactic body radiation therapy in locally advanced pancreatic cancer.

Karyn Aalami Goodman, MD, MS

Latest:

Renowned Gastrointestinal Radiation Oncologist Hired to Lead Clinical Cancer Research at Mount Sinai

Karyn Aalami Goodman, MD, MS, an internationally recognized expert on gastrointestinal cancers, has joined the Icahn School of Medicine at Mount Sinai as Associate Director for Clinical Research at The Tisch Cancer Institute. She is also Professor and Vice Chair for Research and Quality in the Department of Radiation Oncology.

Kashyap Patel, MD

Latest:

Dr. Patel on the Importance of Biosimilars

Kashyap Patel, MD, president of the Carolina Blood and Cancer Center and medical director of the International Oncology Network, discusses the importance of biosimilars in oncology.

Kashyap Patel, MD, Carolina Blood

Kate Jeffers, PharmD University of Colorado Health Memorial Hospital